Skip to main content

LPA1 inhibition induces metastatic dormancy in mouse models of breast cancer



This is really great!

A lysophosphatidic acid receptor 1 (LPAR1) inhibitor, known as Debio-0719, suppresses the development of metastases in mice by inducing cancer cell dormancy, according to astudy published August 21 in the Journal of the National Cancer Institute.

Metastasis is a main contributor to mortality in cancer patients.

Patients with “triple negative” breast cancer (tumour cells that are hormone receptor negative and express normal levels of the HER2 oncogene) are known to be at high risk for metastatic progression.

In addition, breast and prostate cancers are known for having variable but possibly long periods of dormancy, where the disease is silent.

Factors inducing or breaking a dormant state are poorly understood, but extending dormancy is considered a therapeutic goal.

To determine the effects of LPA1 inhibition on metastatic dormancy, Jean-Claude A. Marshall, MSc., Ph.D. of the Women’s Cancers Section, Laboratory of Molecular Pharmacology, Center for Cancer Research, NCI, and colleagues analyzed primary tumour size, distant metastases and their molecular characteristics in two model systems of aggressive “triple negative” breast cancer metastasis, the murine 4T1 mammary carcinoma model and human MDA-MB-231 human breast carcinoma model. Debio-0719 or shRNA knockdown of LPA1 significantly inhibited metastasis formation without affecting primary tumour size.

Tumour cells found in distant organs, such as the lungs and liver of Debio-0719 treated mice, had ceased proliferation and exhibited other molecular hallmarks of dormancy.
LPA1 inhibition represents one of the first compounds to induce dormancy in metastatic sites in triple negative breast cancer.

The authors point out that LPA1 inhibition had no effect on the growth of the primary tumors in either model system. As such, it would not normally be considered further for drug development.
Their data suggest that alternative drug development approaches may identify compounds with novel activities, such as metastatic dormancy.

The authors point out that their study did not determine the duration of tumour dormancy, and that Debio-0719 and other LPA1 inhibitors should be tested in additional model systems.

However, they conclude: “With such inhibitors in hand, the interaction of dormancy pathways and standard of care therapeutics, radiation therapy, patient stress, and other important factors can be determined to develop a deeper picture of potential preventative and therapeutic scenarios.”
Labels:

Comments

Post a Comment

Popular posts from this blog

"Hard nipples" - areola or nipple skin

Someone once wrote"... when i get really cold, or get goosebumbs all over my body, the whole things really scrunch up, like, my entire areola scrunches itself up into a wrinkled little mound. it looks really weird and ugly, and i haven't ever seen other people's breasts do it. what is wrong with my areola/nipples??" The answer: Well nothing is wrong. This is what my areola does too. It's a normal reaction to the coldness or to irritation / stimulation. The little muscles in the areola do a similar goosebump thing as your other skin can do. People often call this phenomenon "hard nipples". Also note that skin on areola has less feeling or sensation to it than other areas of your body. If the areola was very sensitive, then breastfeeding would probably be quite uncomfortable because the baby pulls and tugs it! The nipples are sensitive but the sensitivity changes with hormonal changes, such as occur at mestrual cycle or pregnancy. Also this v...
8 comments
Read more

Ground breaking cancer Carctol Capsule in India with Dr.Vipin Tiwari

Sharing is caring and also very important to keep up with what’s happening in the world. Cancer news we see everyday! This is something I am very very excited about : Changing the future and also saving lives. Sound too good to be true well it’s not the research that has gone into this product is brilliant. Please check out Dr.Vipin Tiwari he is working in India. I was really happy he contacted me to share this product. So I want to share it also with you all. The mission: MISSION "Our mission is to offer products as well as services of the highest professional standards in order to make the whole world Cancer Free." The people at Dr. Nandlal Tiwari Pharmaceuticals Pvt. Ltd. are focused on researching the power of ayurveda, bring up natural medicines & therapies and spread it all over the world for the benfit of mankind. We work hard to bring smiles on hopeless patients of Cancer. With successful records in past and dedication of our employees we are con...
2 comments
Read more

Loosing a parent!

When a Parent Dies: Dealing with the Loss of Your Mother or Father By David Kessler This is spot on. I guess until you go through this you will never know.  #parents #love #grief #davidkessler #survivor #iamstillawoman  When a parent of an adult dies, there is almost an unspoken expectation that it will not hit you head on. An adult is expected to accept death as a part of life, to handle all sudden losses in an appropriate adult manner. But really, what does that mean? That you should not be sad? That you should be so grateful they didn’t die when you were a child that you don’t need to mourn your parent? The above considerations demonstrate an under-estimation of grief. Grief is the reflection of the connection that has been lost. That loss does not diminish because you are an adult or because your mother or father lived a long life. Our society places enormous pressure on us to get over loss, to get through the grief. But how long do you grieve for the man who...
Post a Comment
Read more